Related Experiment Video
Updated: Jun 5, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Heat-Stable Insulins: Any Progress?
1Science Consulting in Diabetes GmbH, Düsseldorf, Germany.
Millions with diabetes lack electricity for insulin storage, risking efficacy due to rising heat. Heat-stable insulin formulations are needed but scarce in development.
Area of Science:
- Endocrinology and Metabolism
- Pharmaceutical Science
Background:
- Limited electricity access affects millions with diabetes, hindering proper insulin storage.
- Increasing global temperatures degrade insulin efficacy when not stored correctly.
- Current insulin formulations require consistent refrigeration, posing challenges for many patients.
Purpose of the Study:
- To highlight the clinical need for heat-stable insulin formulations.
- To discuss challenges and approaches in developing temperature-resilient insulins.
- To address the impact of inadequate insulin storage on diabetes management.
Main Methods:
- This is a commentary, not a primary research study.
- Discussion of existing literature and clinical needs.
- Analysis of challenges in insulin formulation and development.
Main Results:
- A significant gap exists between the need for heat-stable insulin and its availability in clinical development.
- Rising temperatures exacerbate the problem of inadequate insulin storage.
- Current approaches to insulin storage are insufficient for many diabetic patients globally.
Conclusions:
- Developing heat-stable insulin is crucial for improving diabetes care, especially in resource-limited settings.
- Further research and development are needed to bring heat-stable insulin formulations to patients.
- Addressing storage challenges can enhance the glucose-lowering effect and overall management of diabetes.
More Related Videos
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Related Concept Videos
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Glinides
Dipeptidyl Peptidase 4 Inhibitors